Inside the booming business of wellness clubs and third spaces
A few years ago, Grace Guo began longing for places in New York City where going out with friends didn't…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
FDA Vaccine Director to Resign in April After Series of Controversial Decisions
The Food and Drug Administration logo before a news conference at Health and Human Services Headquarters in Washington, April 22,…
FDA Reversals on UniQure, Moderna Approvals Worry Investors
Investors are concerned about the fate of multiple experimental drugs for difficult-to-treat diseases following a series of recent rejections by…
We're dipping into our deep pockets of cash to buy more of this type of healthcare stock.
We are buying 90 shares of Cardinal Health at approximately $217. Following the transaction, Jim Cramer's Charitable Trust will own…
FDA Official Discusses UniQure Gene Therapy for Huntington's Disease
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure needs to conduct another study to show that…
Eli Lilly Launches Program to Increase Employer Coverage of Obesity Drugs
Eli Lilly On Thursday it launched a new program designed to help more employers cover obesity medications in the U.S.,…
News in brief from the world: The latest border clashes between Afghanistan and Pakistan, the murder of an Iraqi women's rights activist is condemned, a milestone in leprosy in Chile
The aid coordination office, OCHA, reported that casualty figures “cannot yet be independently verified” due to limited access. Schools and…
We have been active in trading during the aftermath of the Iran war. Jim Cramer explains our approach
Jim Cramer explained Tuesday morning why the Investment Club is trying to strike a delicate balance with its moves during…
Here's Jim Cramer's Tips for Navigating the Markets During the Iran Conflict
Jim Cramer's advice to investors dealing with the fallout from the US-Israeli attack on Iran: be selective. With stocks initially…
Why Novo Nordisk's expansion in Ireland is key to fighting Eli Lilly
Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capabilities to…